Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Congenica
Congenica
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
Congenica completes $50m series C funding round
The company has established a customer-base of hospitals, diagnostic laboratories, academic medical centres and pharmaceutical companies spanning 18 countries
Recruitment
Congenica appoints CFO
Training & Education
BIA launches Genomics Advisory Committee at annual summit
Recruitment
Congenica appoints new CEO to drive global expansion of clinical genomics
Research & Development
Congenica completes Series B financing with investments from BGI, Healthlink and Future Planet
GI and UniteGen have signed commercial contracts to use Congenica’s enterprise software, Sapientia, to support their operations in China
Analysis
Collaboration speeds up DNA-to-Diagnosis for inherited diseases
The companies aim to accelerate clinicians' ability to use genomics to diagnose a patients’ disease; then make this process available on a global basis
Subscribe now